NM_002454.3:c.1021G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1

The NM_002454.3(MTRR):​c.1021G>A​(p.Val341Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000841 in 1,614,058 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00086 ( 1 hom. )

Consequence

MTRR
NM_002454.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 2.44

Publications

8 publications found
Variant links:
Genes affected
MTRR (HGNC:7473): (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
MTRR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblE
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011435509).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000644 (98/152176) while in subpopulation NFE AF = 0.00129 (88/67992). AF 95% confidence interval is 0.00108. There are 0 homozygotes in GnomAd4. There are 46 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002454.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRR
NM_002454.3
MANE Select
c.1021G>Ap.Val341Ile
missense
Exon 7 of 15NP_002445.2Q9UBK8-2
MTRR
NM_001364440.2
c.1021G>Ap.Val341Ile
missense
Exon 7 of 15NP_001351369.1Q9UBK8-2
MTRR
NM_001364441.2
c.1021G>Ap.Val341Ile
missense
Exon 7 of 15NP_001351370.1Q9UBK8-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRR
ENST00000440940.7
TSL:1 MANE Select
c.1021G>Ap.Val341Ile
missense
Exon 7 of 15ENSP00000402510.2Q9UBK8-2
MTRR
ENST00000264668.6
TSL:1
c.1102G>Ap.Val368Ile
missense
Exon 7 of 15ENSP00000264668.2Q9UBK8-1
MTRR
ENST00000513439.5
TSL:1
n.*728G>A
non_coding_transcript_exon
Exon 7 of 15ENSP00000426710.1D6RF21

Frequencies

GnomAD3 genomes
AF:
0.000644
AC:
98
AN:
152058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00128
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000616
AC:
155
AN:
251452
AF XY:
0.000692
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.00122
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000861
AC:
1259
AN:
1461882
Hom.:
1
Cov.:
35
AF XY:
0.000847
AC XY:
616
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.000168
AC:
9
AN:
53420
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00108
AC:
1200
AN:
1112006
Other (OTH)
AF:
0.000580
AC:
35
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000644
AC:
98
AN:
152176
Hom.:
0
Cov.:
32
AF XY:
0.000618
AC XY:
46
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41520
American (AMR)
AF:
0.000131
AC:
2
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00129
AC:
88
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000900
Hom.:
1
Bravo
AF:
0.000552
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.000692
AC:
84
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.00130

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Methylcobalamin deficiency type cblE (2)
-
1
-
Disorders of Intracellular Cobalamin Metabolism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
8.4
DANN
Uncertain
0.99
Eigen
Benign
0.018
Eigen_PC
Benign
0.019
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
1.3
L
PhyloP100
2.4
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.20
Sift
Benign
0.32
T
Sift4G
Benign
0.58
T
Vest4
0.092
MVP
0.60
MPC
0.076
ClinPred
0.038
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.060
gMVP
0.25
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74790259; hg19: chr5-7885931; COSMIC: COSV106358199; COSMIC: COSV106358199; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.